Sharekhan

#SharekhanResearch recommend Buy on Amber with PT of Rs2623, Better-than-expected #Q2FY21 led by healthy subsidiari… https://t.co/YVpK8GASs7 #SharekhanResearch #Q2FY21

#SharekhanFNA #SharekhanResearch retains Buy on #Divislabs (PT Rs 3800); reports a sturdy performance for #Q2FY21;… https://t.co/55TPmhUfeN #SharekhanFNA #SharekhanResearch #Divislabs #Q2FY21

#SharekhanResearch maintains Hold on Bank of India with PT of Rs 45, #Q2FY21earnings in-line: operating results bea… https://t.co/nEJdDD855J #SharekhanResearch #Q2FY21earnings

#SharekhanFNA #SharekhanResearch retains Hold on #Lupin (PT Rs 1040) #Q2FY21 was a weak quarter; gradual improvemen… https://t.co/6FjD5N4B5n #SharekhanFNA #SharekhanResearch #Lupin #Q2FY21

#SharekhanResearch maintains Buy on SBI with PT of Rs 280, #Q2FY21earnings in-line: Asset Qlty performance mixed wi… https://t.co/Jwx3BdVDew #SharekhanResearch #Q2FY21earnings

#SharekhanFNA #SharekhanResearch retains Buy rating on #SolaraActivePharma (PT Rs 1371) #Q2FY21 was a strong quarte… https://t.co/XIRhvNBfQD #SharekhanFNA #SharekhanResearch #SolaraActivePharma #Q2FY21

#SharekhanFNA #SharekhanResearch retains Buy rating on #LaurusLabs (PT Rs385) #Q2FY21 is strong quarter; Formulatio… https://t.co/EgcQc1MG77 #SharekhanFNA #SharekhanResearch #LaurusLabs #Q2FY21

#SharekhanResearch maintains Positive view on Indusind Bank and see 20-22% upsides, #Q2FY21earnings mixed: improved… https://t.co/mcLDgWrAhp #SharekhanResearch #Q2FY21earnings

#SharekhanResearch maintain Buy on ICICI Bank with Price target of Rs 525, #Q2FY21earnings strong: Collections impr… https://t.co/v92g3TppmP #SharekhanResearch #Q2FY21earnings